Dr Agnieszka Michael MBBS PhD MRCP
Dr Michael qualified in medicine from Wroclaw University in Poland in 1994 and received a doctorate in cancer gene therapy from St George’s, University of London in 2006. She trained in Medical Oncology at the Royal Marsden Hospital, St George’s Hospital, London, and Guys and Thomas’s Hospital. She has been working at the University of Surrey as a Senior Lecturer, Department of Microbial and Cellular Sciences since 2008. She also works as a Consultant Medical Oncologist at the Royal Surrey County Hospital. Dr Michael’s key research specialities are in the areas of Ovarian Cancer and urological malignancies .
Dr Michael is a member of NCRN Clinical Studies Group for Gynaecological Cancers and has experience in running national and international clinical trials for new cancer treatments as a local Principal Investigator and a UK Chief Investigator. She has recently been successful in obtaining CTAAC/CRUK approval for a new investigator-driven multi-centre study of a TroVax vaccine in ovarian cancer (TRIOC) which is due to run in 10 centres in UK. Dr Michael also supervises a number of translational sciences projects, mainly in gynaecological cancers and has set up a tissue bank based at at the University of Surrey, which is now become a part of the NCRI on Core UK-Confederation of Cancer Biobanks (CCB).
View Dr Michael's academic profile: http://www.surrey.ac.uk/fhms/people/atoz/agnieszka_michael/
Dr Vikki Revell
Vikki joined Surrey CRC as a Project Manager in 2010 and is now Head of Research and Study Management with responsibility for the Project Management, Data Management and Statistics teams. Vikki has been involved in Phase I – IV trials in the areas of sleep/wake, circadian rhythms, vaccines, and oncology.
Vikki obtained a degree in Biology from Imperial College in 2000 and her PhD in Neuroendocrinology in the University of Surrey in 2004. Prior to working at the CRC Vikki worked as a post-doctoral researcher in Chicago, Manchester and Surrey investigating the impact of light on human circadian rhythms, metabolism and sleep, and developing interventions for minimising the negative effects of jet lag and night shift work on health and well-being.
Beth joined Surrey CRC as a Data Manager in August 2015 and has since been appointed as Operational Manager for the CTU. Prior to this Beth spent nearly 10 years at the Medical Research Council Clinical Trials Unit, first as a Trial Manager and later as a Project Manager. Beth primarily worked on multi-centre, multi-national Phase III trials. Beth has also worked on other trials and research studies at Imperial College and the Institute of Cancer Research – Cancer Screening Evaluation Unit.
Beth obtained her degree in Medical Sciences (BMedSc) at the University of Birmingham in 1999.
Kathryn joined Surrey in May 2016. Prior to this Kathryn worked in the QA team at The Pirbright Institute and as an Analyst for Thames Water.
Kathryn obtained her degree in Natural Science (Chemistry and Biology) from Durham University in 2011.
The CTU also has links to expertise within the university including:
- Clinical Research Facility – Phase I-II clinical trials
- Sleep & Circadian rhythms – advanced research facilities and equipment – lab and home
- Real World Evidence Centre, big data analysis
- Secure (NHS approved) network and access to RCGP Research and Surveillance Centre data (over 2 million) for study participants/approval
- Living lab – supervised living accommodation for device and monitoring trials in patient groups.
- Advanced technologies (5G, Engineering for Health)
- Veterinarian medicine / Zoonosis